Sky Investment Group LLC Buys 347 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Sky Investment Group LLC boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 2.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 13,306 shares of the healthcare conglomerate’s stock after purchasing an additional 347 shares during the period. Sky Investment Group LLC’s holdings in UnitedHealth Group were worth $6,731,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Delta Financial Group Inc. raised its holdings in shares of UnitedHealth Group by 1.0% during the 3rd quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate’s stock worth $965,000 after acquiring an additional 17 shares during the period. First PREMIER Bank boosted its holdings in UnitedHealth Group by 7.0% in the 3rd quarter. First PREMIER Bank now owns 274 shares of the healthcare conglomerate’s stock valued at $160,000 after purchasing an additional 18 shares during the last quarter. Genesee Capital Advisors LLC increased its holdings in shares of UnitedHealth Group by 1.9% during the 3rd quarter. Genesee Capital Advisors LLC now owns 990 shares of the healthcare conglomerate’s stock worth $579,000 after buying an additional 18 shares during the last quarter. Jmac Enterprises LLC lifted its holdings in UnitedHealth Group by 2.2% in the third quarter. Jmac Enterprises LLC now owns 823 shares of the healthcare conglomerate’s stock valued at $481,000 after acquiring an additional 18 shares during the last quarter. Finally, Matrix Private Capital Group LLC raised its position in UnitedHealth Group by 3.6% in the second quarter. Matrix Private Capital Group LLC now owns 542 shares of the healthcare conglomerate’s stock valued at $276,000 after purchasing an additional 19 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of analysts recently issued reports on UNH shares. Oppenheimer raised their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Royal Bank of Canada decreased their price objective on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a report on Wednesday, October 16th. Piper Sandler cut their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. Stephens lifted their price objective on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research note on Thursday, December 5th. Finally, StockNews.com cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Wednesday, January 15th. Two equities research analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, UnitedHealth Group presently has an average rating of “Buy” and an average price target of $627.74.

UnitedHealth Group Price Performance

Shares of UNH opened at $510.03 on Tuesday. The firm has a fifty day moving average price of $549.37 and a 200 day moving average price of $563.70. The stock has a market cap of $469.37 billion, a PE ratio of 32.91, a price-to-earnings-growth ratio of 1.39 and a beta of 0.62. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm’s revenue was up 6.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $5.83 earnings per share. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.77 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were given a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.65%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.